Metropolitan Worldwide Receives Additional $1.0 Million in Financing From Private Placement Offering.

FORT LAUDERDALE, Fla. & KREUZLINGEN, Switzerland -- Metropolitan Worldwide, Inc. (Pink Sheets:MWWM - News), a Ft. Lauderdale, Florida-based company - hereinafter "MWWM" or the "Company" -- today announced that it has sold an additional 1,000,000 shares of its common stock for USD $1,000,000 in a private placement. The proceeds from the offering, together with the proceeds of a prior private placement, will be principally used to accelerate the marketing and distribution of Metro NicStic (www.nicstic.com), a unique brand of non-smoking cigarettes, in Europe, Asia and, eventually, the United States, as well as purchase shares of common stock of NicStic AG, the patent holder for Metro NicStic.

On February 23rd 2005, Metropolitan's German counsel got the green light from the office of the President of the German Federal State of Saxony that NicStic can be distributed in Germany without prescription. This was the first official published legal opinion and a major step for MWWM towards the establishment of distribution activities in the European Community. The company will now also seek approval from Food and Drug Agencies throughout the rest of the world and expects shortly to announce the engagement of a major US law firm to assist us in such efforts.

Commenting on this important development, Evert Wilbrink, CEO of the Company, stated: "We are pleased to have completed another round of financing in a very short period of time and we are contemplating a third round of financing, likely in July 2005. The proceeds from this financing round will enable us to additionally support our key distributors in the process of setting up global distribution".

Mr. Wilbrink further stated: "Between the two private placements that we have recently completed, we feel that we are poised to commence our marketing and distribution of NicStics on a global basis in the fourth quarter of 2005. One of our goals is to be able to provide NicStics to smokers everywhere. With non-smoking areas increasing, especially in restaurants and other public places, we believe that the NicStic will be able to satisfy smokers everywhere, allowing them to enjoy themselves in public settings without offending non-smokers".

In March 2004, MWWM acquired the US licensing and exploitation rights for "MetroNicStic" from the Swiss company, NicStic AG. In January 2005, this license was modified to become worldwide. Meanwhile, recent anti-smoking laws in the Irish Republic, Norway and Italy have led to significant cultural change. It would appear that the UK, France and Belgium are soon to follow. The introduction of the smoke-free cigarette NicStic is in perfect accord with this development, as the NicStic product remain unaffected by anti-smoking legislation.

Disclaimer: Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements."

Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates", believes", "understand", "will", "anticipates", or that by statements indicating certain actions "may", "could", or "might" occur. All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. In compliance with Section 17(b), we disclose the holding of independently purchased shares of MWWM prior to the publication of this report. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company.